Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
22 participants
OBSERVATIONAL
2021-03-11
2021-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sweat Sensors for Athletic Performance
NCT03566381
Lymphedema Sensor Technology Development Study
NCT06778837
Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis
NCT03874039
Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature
NCT05640310
Device to Reduce Surgery Site Contamination
NCT00972153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Febrile (n=50)
Febrile is defined as having sublingual temperatures of 37.5 °C or above. All subjects will wear the Verily Patch in the axillary region for up to 8 days. In addition, subjects will measure oral and axillary temperatures using a commercially available thermometer.
Verily Patch
The Verily Patch is an investigational wearable temperature sensor that consists of a Patch (Verily Patch), with swappable adhesives, as well as an app (Verily Patch app).
Afebrile (n=50)
Afebrile is defined as having sublingual temperatures of less than 37.5 °C. All subjects will wear the Verily Patch in the axillary region for up to 8 days. In addition, subjects will measure oral and axillary temperatures using a commercially available thermometer.
Verily Patch
The Verily Patch is an investigational wearable temperature sensor that consists of a Patch (Verily Patch), with swappable adhesives, as well as an app (Verily Patch app).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verily Patch
The Verily Patch is an investigational wearable temperature sensor that consists of a Patch (Verily Patch), with swappable adhesives, as well as an app (Verily Patch app).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and speak English
* Able to read and understand the Informed Consent Form
* Willing to wear Verily Patch in the axillary region
* Willing to comply with repeated self-measurement of oral and axillary temperatures and willing to record temperature readings
* Have a working smartphone device and willing to use it for study activities
* Willing to install study apps on their personal smartphone
* Willing to comply with all study-related procedures
Exclusion Criteria
* Have known allergies to medical grade adhesives
* Have known cutaneous hypersensitivity
* Have infection in both axilla
* Have open injury or rash where the study device will be worn
* Have a cardiac pacemaker or other implanted electronic medical device(s)
* Have any additional condition or situation that, in the opinion of the investigator, makes the subject inappropriate for participation in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Verily Life Sciences LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Marks, MD
Role: STUDY_DIRECTOR
Verily Life Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UT Southwestern Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102782
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.